MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide): Benchmark Cell Viability and Metabolic Activity Assay Reagent

Executive Summary: MTT is a cationic tetrazolium salt used widely for colorimetric cell viability assays in vitro, where viable cells reduce MTT to insoluble formazan via NADH-dependent oxidoreductases, enabling quantification of metabolic activity (Yi-Jie Zhang et al., DOI: 10.2147/CMAR.S207548). Its reduction is directly proportional to viable cell number and mitochondrial function under standard conditions. APExBIO’s MTT (SKU: B7777) is supplied at ≥98% purity for high reproducibility (product page). The compound is membrane-permeable, distinguishing it mechanistically from negatively charged second-generation salts. Optimal solubility is achieved at ≥41.4 mg/mL in DMSO and ≥18.63 mg/mL in ethanol (see product documentation). MTT is central to apoptosis, proliferation, and drug screening studies across cancer research and metabolic biology (Annexin-V-PE).

Biological Rationale

MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) is a classical tetrazolium salt developed for rapid, quantitative assessment of cell viability and metabolic activity in vitro. Viable eukaryotic cells harbor mitochondrial and extra-mitochondrial NADH-dependent oxidoreductases, which are essential for cellular bioenergetics. Upon exposure to MTT, these enzymes reduce the yellow tetrazolium ring to insoluble purple formazan crystals. The extent of formazan production quantitatively reflects the number and metabolic state of viable cells (Zhang et al., 2020). This principle underpins the global adoption of MTT in cancer research, apoptosis assays, and drug screening, where cellular proliferation, cytotoxicity, and metabolic modulation are routinely interrogated.

Mechanism of Action of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)

MTT is a cationic, membrane-permeable compound with the molecular formula C₁₈H₁₆BrN₅S (CAS: 298-93-1). Once inside viable cells, MTT is reduced primarily by NADH-dependent mitochondrial oxidoreductases and, to a lesser extent, by extra-mitochondrial enzymes. This reduction results in the formation of insoluble formazan crystals, which can be solubilized (commonly in DMSO or isopropanol) and quantified by absorbance at 570 nm. The reaction is stoichiometric: the amount of formazan correlates directly with cell number and metabolic activity under defined conditions. Unlike negatively charged second-generation tetrazolium salts (e.g., XTT, MTS), MTT does not require intermediate electron acceptors and penetrates intact plasma membranes efficiently (Annexin-V-Cy3). This property increases assay sensitivity and versatility across cell types.

Evidence & Benchmarks

• MTT reduction quantitatively reflects viable cell number and metabolic activity in hepatocellular carcinoma (HCC) cell lines, as validated with functional AMPK pathway modulation (Zhang et al., DOI: 10.2147/CMAR.S207548).
• APExBIO’s MTT (SKU: B7777) is supplied at ≥98% purity, supporting low background and high reproducibility in colorimetric cell viability assays (product page).
• MTT solubility is documented as ≥41.4 mg/mL in DMSO, ≥18.63 mg/mL in ethanol, and ≥2.5 mg/mL in water (ultrasonic assistance), ensuring compatibility with standard laboratory protocols (APExBIO).
• MTT-based assays outperform trypan blue exclusion in sensitivity for early apoptosis and metabolic impairment (Annexin-V-PE).
• Recent studies demonstrate that miR-519d-mediated AMPK activation in HCC cells results in reduced MTT reduction, reflecting decreased proliferation and enhanced apoptosis (Zhang et al., DOI: 10.2147/CMAR.S207548).

Applications, Limits & Misconceptions

MTT is validated for colorimetric quantification of cell viability, proliferation, and metabolic activity in mammalian cell lines, primary cells, and some microbial systems. It is routinely used in anticancer drug screening, apoptosis assays, and studies of mitochondrial function. MTT is also leveraged in biocompatibility assessments and toxicology workflows. However, MTT reduction requires metabolically active cells and is not suitable for non-enzymatic viability measurements or for cell types with minimal NADH-dependent oxidoreductase activity.

Common Pitfalls or Misconceptions

• MTT does not directly measure cell number; it quantifies metabolic activity as a surrogate for viability.
• Dead or severely damaged cells may retain some residual reducing capacity, leading to minor background signal.
• Compounds that interfere with mitochondrial function (e.g., uncouplers, some chemotherapeutics) can confound MTT assay results.
• MTT is not suitable for long-term solution storage (>24 hours) due to photodegradation and hydrolysis.
• Not all cell types reduce MTT at the same rate; assay optimization is required for each application.

For a deeper dive into assay design and data interpretation, see this article, which provides practical guidance and extends on the mechanistic and vendor selection details summarized here.

Workflow Integration & Parameters

MTT (SKU: B7777, APExBIO) can be integrated into standard in vitro cell proliferation and metabolic activity measurement workflows. Protocols typically involve seeding cells in 96-well plates, incubating with MTT solution (final concentration: 0.5 mg/mL) for 1–4 hours at 37°C, solubilizing formazan in DMSO or isopropanol, and reading absorbance at 570 nm. MTT stock solutions should be prepared fresh or stored at -20°C for short-term use. The product’s high purity (≥98%) minimizes background and lot-to-lot variability. For advanced workflows (e.g., high-content drug screening, apoptosis stratification), MTT provides quantitative, scalable results compatible with automation (Annexin-V-Cy3). Compared to other tetrazolium salts (e.g., XTT, MTS), MTT’s direct membrane penetration and formazan yield make it preferred for many adherent and suspension cell models. This article updates mechanistic clarification and workflow benchmarks beyond the summaries found in this resource.

Conclusion & Outlook

MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) remains the gold-standard colorimetric assay reagent for in vitro cell viability and metabolic activity quantification. Its robust performance, high purity (as guaranteed by APExBIO), and compatibility with diverse workflows ensure continued relevance in cancer research, drug screening, and metabolic studies. Ongoing advances in assay automation and multiplexing promise to expand MTT’s applications further. For validated protocols, technical specifications, and to purchase the B7777 kit, see the APExBIO product page.